Tribos LLC develops recombinant human lubricin for the treatment of dry eye, osteoarthritis and other age, and inflammation-related conditions. The company was founded by Edward R. Truitt, Harry Barnett, Edmund R. Pitcher and Benjamin D. Sullivan and is headquartered in Framingham, MA.

Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. Viking’s research and development activities leverage the Company’s expertise in metabolism to develop innovative therapeutics that improve patients’ lives. The Company’s lead clinical program is VK0612, a first-in-class, orally available drug candidate type 2 diabetes. The Company’s second clinical program is VK5211, an orally available, non-steroidal selective androgen receptor modulator, or SARM, for the treatment of cancer cachexia. Viking is also developing three novel preclinical programs targeted at metabolic diseases and anemia.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Mars, Inc. engages in the production of confectionery and animal food products. Its brands include M&M?s, Snickers, Twix, Milky Way, Dove, Pedigree, Whiskas, Extra, Skittles, Uncle Ben's, and Cocoavia. The company was founded by Franklin Clarence Mars in 1911 and is headquartered in McLean, VA.

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

CELLPROTEK provides small molecule drugs for the treatment of major diseases of the central nervous system. They also create medications for acute ischemia stroke, alzheimer's disease, cardiovascular, cerebrovascular, and neurodegenerative diseases.

Shenzhen Shankang Pharmaceutical Technology Co., Ltd., established on 2017-10-24, Business scope includes general business items:Research in Medical Technology,development and transfer;Medical Technology Services;Medical Technology Consulting,Information Consulting;Medical Device Research,development and transfer;Invest in business,Medical project investment;Domestic Trade;Import and export of goods or technology;Operating import and export business(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating).,The licensing program is:drug research,development and sales;Internet hospital services relying on physical hospitals;The second type of value-added telecommunications services;Sales of Class II Medical Devices;Internet culture management.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

The Texas A&M University System creates a seamless pathway for students to earn an associate and bachelor’s degree in related fields

The Feinstein Institutes for Medical Research comprise the research arm of Northwell Health. Feinstein is home to 50 research labs, 2,500 clinical research studies, and 4,000 professional and support staff. Feinstein researchers have made breakthroughs in molecular medicine, genetics, cancer, brain research, mental health, autoimmunity and bioelectronic medicine, among others, and continue work in those and other areas. Feinstein is the laboratory and faculty home of the Elmezzi Graduate School of Molecular Medicine. Additionally, students without an MD degree may earn a PhD in molecular medicine via the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, as part of the medical school's MD/PhD or PhD programs.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Nanjing Nuowei Biotechnology Partnership LP is a Chinese private company involved in biological products, except diagnostic substances.

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders. The company is led by an experienced team of scientists and industry experts, and supported by a panel of advisors with a strong track record of discovering and developing new and innovative therapies. Disc Medicine was founded by Atlas Venture and Brian MacDonald, with Novo Ventures and Access Biotechnology joining as additional investors.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).